SOLOMON ALLIANCE GROUP, INC. | TalkMarkets

Latest Posts

Dow Rises Over 300 Points To Start The Week

Article By: Schaeffers Research

Monday, August 7, 2023 12:14 PM EDT

The Dow Jones Industrial Average was last seen up 308 points, as the blue-chip index looks to start the week on a high note following its recent losses.

In this article: TSN, QQQ, SAGE, SPX, VIX, DJI, TRHC, BIIB

Read

June’s Best And Worst Performing Russell 1,000 Stocks

Article By: Bespoke Investment Group

Tuesday, June 29, 2021 3:00 PM EDT

The month of June, the second quarter and the first half of 2021 are almost in the bag.

In this article: FCS, LUV, NEM, RS, UPST, EXEL, SAGE, AAL, RUN, IOVA, FSLY, SPCE, CVAC, SKLZ, TSP

Read

VistaGen Therapeutics Announces Positive Meeting With FDA Regarding Pivotal Phase 3 Study Of PH94B For Acute Treatment Of Anxiety In Patients With Social Anxiety Disorder

Article By: TalkMarkets Newswire

Thursday, July 23, 2020 9:00 AM EDT

VistaGen and the FDA reached consensus on key aspects of a unique initial pivotal Phase 3 clinical trial of PH94B involving a single-event, laboratory-simulated public speaking challenge in adult patients with SAD.

In this article: VTGN Also: IMMP, ARTX, SAGE, RLMD, BHVN

Read

VistaGen Therapeutics And EverInsight Therapeutics Enter Strategic Collaboration To Develop And Commercialize PH94B For Anxiety Disorders In Greater China, South Korea And Southeast Asia

Article By: TalkMarkets Newswire

Thursday, June 25, 2020 8:03 AM EDT

The collaboration is intended to support Phase 3 development and commercialization of PH94B in key Asian markets. The agreement includes a $5 million upfront payment and development and commercial milestones up to $172 million.

In this article: VTGN Also: ARTX, SAGE, RLMD, BHVN

Read